692 related articles for article (PubMed ID: 30962421)
1. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis.
Zou Y; Palte MJ; Deik AA; Li H; Eaton JK; Wang W; Tseng YY; Deasy R; Kost-Alimova M; Dančík V; Leshchiner ES; Viswanathan VS; Signoretti S; Choueiri TK; Boehm JS; Wagner BK; Doench JG; Clish CB; Clemons PA; Schreiber SL
Nat Commun; 2019 Apr; 10(1):1617. PubMed ID: 30962421
[TBL] [Abstract][Full Text] [Related]
2. Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.
Emerling BM; Benes CH; Poulogiannis G; Bell EL; Courtney K; Liu H; Choo-Wing R; Bellinger G; Tsukazawa KS; Brown V; Signoretti S; Soltoff SP; Cantley LC
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3483-8. PubMed ID: 23378636
[TBL] [Abstract][Full Text] [Related]
3. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.
Miess H; Dankworth B; Gouw AM; Rosenfeldt M; Schmitz W; Jiang M; Saunders B; Howell M; Downward J; Felsher DW; Peck B; Schulze A
Oncogene; 2018 Oct; 37(40):5435-5450. PubMed ID: 29872221
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
6. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
7. The α6β4 integrin promotes resistance to ferroptosis.
Brown CW; Amante JJ; Goel HL; Mercurio AM
J Cell Biol; 2017 Dec; 216(12):4287-4297. PubMed ID: 28972104
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.
Liu W; Chen H; Wong N; Haynes W; Baker CM; Wang X
Cancer Lett; 2017 May; 394():65-75. PubMed ID: 28257806
[TBL] [Abstract][Full Text] [Related]
9. Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy.
Rustum YM; Chintala S; Durrani FA; Bhattacharya A
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380599
[TBL] [Abstract][Full Text] [Related]
10. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.
Yang WS; Kim KJ; Gaschler MM; Patel M; Shchepinov MS; Stockwell BR
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E4966-75. PubMed ID: 27506793
[TBL] [Abstract][Full Text] [Related]
11. FSP1 is a glutathione-independent ferroptosis suppressor.
Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ferroptotic cancer cell death by GPX4.
Yang WS; SriRamaratnam R; Welsch ME; Shimada K; Skouta R; Viswanathan VS; Cheah JH; Clemons PA; Shamji AF; Clish CB; Brown LM; Girotti AW; Cornish VW; Schreiber SL; Stockwell BR
Cell; 2014 Jan; 156(1-2):317-331. PubMed ID: 24439385
[TBL] [Abstract][Full Text] [Related]
13. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
[TBL] [Abstract][Full Text] [Related]
14. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
15. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
[TBL] [Abstract][Full Text] [Related]
16. [Effect of GPX4 on proliferation and metastasis of renal clear cell carcinoma and its relationship with expression of IGF-1R and COX-2].
Su Y; Zhao A; Chen AP; Liu XZ; Tian YP; Jin JY
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):955-960. PubMed ID: 31818070
[No Abstract] [Full Text] [Related]
17. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway.
Chu B; Kon N; Chen D; Li T; Liu T; Jiang L; Song S; Tavana O; Gu W
Nat Cell Biol; 2019 May; 21(5):579-591. PubMed ID: 30962574
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis.
Hu CL; Nydes M; Shanley KL; Morales Pantoja IE; Howard TA; Bizzozero OA
J Neurochem; 2019 Feb; 148(3):426-439. PubMed ID: 30289974
[TBL] [Abstract][Full Text] [Related]
19. Targeting renal cell carcinoma with a HIF-2 antagonist.
Chen W; Hill H; Christie A; Kim MS; Holloman E; Pavia-Jimenez A; Homayoun F; Ma Y; Patel N; Yell P; Hao G; Yousuf Q; Joyce A; Pedrosa I; Geiger H; Zhang H; Chang J; Gardner KH; Bruick RK; Reeves C; Hwang TH; Courtney K; Frenkel E; Sun X; Zojwalla N; Wong T; Rizzi JP; Wallace EM; Josey JA; Xie Y; Xie XJ; Kapur P; McKay RM; Brugarolas J
Nature; 2016 Nov; 539(7627):112-117. PubMed ID: 27595394
[TBL] [Abstract][Full Text] [Related]
20. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
